These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2447714)

  • 1. Crystal structure of a 1,4-dihydropyridine with enantiomers showing opposite effects on calcium channels: structural features of calcium channel agonists and antagonists.
    Fossheim R
    Acta Chem Scand B; 1987 Sep; 41(8):581-8. PubMed ID: 2447714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
    Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
    J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and crystal structure of optically active 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate (NZ-105).
    Sakoda R; Matsumoto H; Seto K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2377-81. PubMed ID: 1446358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine.
    Hof RP; Rüegg UT; Hof A; Vogel A
    J Cardiovasc Pharmacol; 1985; 7(4):689-93. PubMed ID: 2410709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative ion mass spectra of dihydropyridine calcium-channel blockers.
    Ehrhardt JD; Ziegler JM
    Biomed Environ Mass Spectrom; 1988 May; 15(10):525-8. PubMed ID: 3408820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor model for the molecular basis of tissue selectivity of 1, 4-dihydropyridine calcium channel drugs.
    Langs DA; Strong PD; Triggle DJ
    J Comput Aided Mol Des; 1990 Sep; 4(3):215-30. PubMed ID: 2177783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine.
    Fossheim R; Svarteng K; Mostad A; Rømming C; Shefter E; Triggle DJ
    J Med Chem; 1982 Feb; 25(2):126-31. PubMed ID: 7057416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational features of calcium channel agonist and antagonist analogs of nifedipine.
    Langs DA; Triggle DJ
    Mol Pharmacol; 1985 May; 27(5):544-8. PubMed ID: 2581123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dihydropyridine calcium agonists and antagonists on neuronal voltage sensitive calcium channels.
    Creba JA; Karobath M
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1038-47. PubMed ID: 2418832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
    Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA
    J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channels in the heart. Properties and modulation by dihydropyridine enantiomers.
    Reuter H; Porzig H; Kokubun S; Prod'hom B
    Ann N Y Acad Sci; 1988; 522():16-24. PubMed ID: 2454050
    [No Abstract]   [Full Text] [Related]  

  • 12. Stereoselective pharmacokinetics of dihydropyridine calcium antagonists.
    Tokuma Y; Noguchi H
    J Chromatogr A; 1995 Mar; 694(1):181-93. PubMed ID: 7719464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective determination and pharmacokinetics of dihydropyridines: an updated review.
    Inotsume N; Nakano M
    J Biochem Biophys Methods; 2002 Dec; 54(1-3):255-74. PubMed ID: 12543503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of dihydropyridine calcium channel blockers using negative ion photoionization mass spectrometry.
    Pereira AS; Bicalho B; Ilha JO; De Nucci G
    J Chromatogr Sci; 2008 Jan; 46(1):35-41. PubMed ID: 18218186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 1,4-dihydropyridine-5-phosphonates and their calcium-antagonistic and antihypertensive activities: novel calcium-antagonist 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate hydrochloride ethanol (NZ-105) and its crystal structure.
    Sakoda R; Kamikawaji Y; Seto K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2362-9. PubMed ID: 1446356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
    Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM
    Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and X-ray crystal structure of the calcium channel antagonist: dimethyl 1,4-dihydro-2,6-dimethyl-4-[4'-(4H-4-oxo-1-benzopyran-2-yl)phenyl]- 3,5-pyridine dicarboxylate.
    Tunçbilek M; Ozbey S; Kendi E; Yildirim E; Erol K; Ertan R
    Farmaco; 1999 Oct; 54(10):660-5. PubMed ID: 10575734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of newly synthesized racemic dihydropyridines with different chiral selectors by means of capillary electrophoresis.
    Christians T; Diewald D; Wessler C; Otte Y; Lehmann J; Holzgrabe U
    J Chromatogr A; 1999 Aug; 853(1-2):455-60. PubMed ID: 10486753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses, calcium channel agonist-antagonist modulation activities, and nitric oxide release studies of nitrooxyalkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate racemates, enantiomers, and diastereomers.
    Shan R; Velazquez C; Knaus EE
    J Med Chem; 2004 Jan; 47(1):254-61. PubMed ID: 14695839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diethyl 3,6-dihydro-2,4-dimethyl-2,6-methano-1,3-benzothiazocine-5,11- dicarboxylates as calcium entry antagonists: new conformationally restrained analogues of Hantzsch 1,4-dihydropyridines related to nitrendipine as probes for receptor-site conformation.
    Baldwin JJ; Claremon DA; Lumma PK; McClure DE; Rosenthal SA; Winquist RJ; Faison EP; Kaczorowski GJ; Trumble MJ; Smith GM
    J Med Chem; 1987 Apr; 30(4):690-5. PubMed ID: 2435904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.